Intensity-Modulated Radiation Therapy With or Without Concurrent Chemotherapy in Nonanaplastic Thyroid Cancer with Unresectable or Gross Residual Disease.
暂无分享,去创建一个
N. Lee | R. Wong | N. Riaz | J. Fagin | R. Tuttle | S. McBride | A. Shaha | E. Sherman | C. Tsai | P. Romesser | M. Sabra | T. Beckham | C. J. Tsai | D. Spielsinger | Andries H Groen | C. Sabol | T. Brinkman
[1] S. Mandel,et al. American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with , 2017, Thyroid : official journal of the American Thyroid Association.
[2] B. Haugen,et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed? , 2017, Cancer.
[3] A. Jemal,et al. Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.
[4] N. Lee,et al. External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non‐anaplastic non‐medullary thyroid cancer , 2014, Journal of surgical oncology.
[5] N. Lee,et al. The role of radiation therapy in the treatment of medullary thyroid cancer. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.
[6] A. Garden,et al. Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment. , 2009, International journal of radiation oncology, biology, physics.
[7] M. Zelefsky,et al. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience. , 2009, International journal of radiation oncology, biology, physics.
[8] D. Dearnaley,et al. Intensity Modulated Radiotherapy (IMRT) in locally advanced thyroid cancer: acute toxicity results of a phase I study. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] C. Kwan,et al. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition. , 2006, Endocrine-related cancer.
[10] J. Shah,et al. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis , 2006, Cancer.
[11] M. Papotti,et al. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns , 2004, Cancer.
[12] C. N. Coleman,et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. , 2003, Seminars in radiation oncology.
[13] R. Kloos,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society CLINICAL REVIEW 128 Current Approaches to Primary Therapy for Papillary , 2022 .
[14] A. Shaha,et al. Thyroid carcinoma , 1998, Cancer.
[15] T. Pajak,et al. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.
[16] M. Ranney,et al. Beyond the bedside: Clinicians as guardians of public health, medicine and science , 2020, The American Journal of Emergency Medicine.
[17] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[18] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[19] J. Yates,et al. Evaluation of patients with advanced cancer using the karnofsky performance status , 1980, Cancer.